Recurrence of Thrombotic Thrombocytopenic Purpura after mRNA-1273 COVID-19 Vaccine Administered Shortly after COVID-19
Thrombotic thrombocytopenic purpura (TTP) is a potentially life-threatening consumptive coagulopathy requiring emergent diagnosis and timely treatment. It is characterized by microangiopathic hemolytic anemia and thrombocytopenia with the development of microthrombi caused by inherited or acquired d...
Main Authors: | Korin Karabulut, Ana Andronikashvili, Ahmet Hakki Kapici |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2021/4130138 |
Similar Items
-
COVID-19 and Thrombotic Thrombocytopenic Purpura: A Case Report
by: Maryam Darnahal, et al.
Published: (2021-01-01) -
Relapse of Immune Thrombotic Thrombocytopenic Purpura Following Vaccination with COVID19 mRNA Vaccine
by: Katerina Pavenski
Published: (2021-07-01) -
Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination
by: Bellal, M., et al.
Published: (2022) -
Critical Care COVID-19 Patient with a Picture of Thrombotic Thrombocytopenic Purpura
by: Rehab AL-Ansari, et al.
Published: (2020-12-01) -
A COVID-19 pregnant patient with thrombotic thrombocytopenic purpura: a case report
by: Soheila Aminimoghaddam, et al.
Published: (2021-03-01)